Merck Cancels £1bn UK Expansion Amid Claims of Poor Government Support
The UK pharmaceutical sector has suffered a major setback after U.S. drugmaker Merck & Co., known as MSD in Europe, announced it is abandoning plans for a £1 billion expansion in London. The company will instead move its life sciences research to the U.S., citing what it described as years of insufficient government investment in…